SFRP4 and pancreatic neoplasm: The mRNA expression levels of SFRP2 and SFRP4 were significantly elevated in the breast, gastric, and pancreatic cancer tissues, while SFRP1 showed significantly decreased expression in datasets from 15 different types of cancer.